iBio, Inc. (IBIO) › Operating Cash FlowiBio, Inc. (IBIO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$5.34M2012: -$6.01M2013: -$4.85M2017: -$13.16M2018: -$13.48M2019: -$13.97M2020: -$13.35M2021: -$30.06M2022: -$37.48M2023: -$30.44M2024: -$18.55M2025: -$15.30M-$15.30M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$15.30M+17.5%2024-$18.55M+39.0%2023-$30.44M+18.8%2022-$37.48M-24.7%2021-$30.06M-125.3%2020-$13.35M+4.5%2019-$13.97M-3.7%2018-$13.48M-2.4%2017-$13.16M—2013-$4.85M+19.3%2012-$6.01M-12.6%2011-$5.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share